YU49699A - Pharmaceutical compositions and process for their production - Google Patents
Pharmaceutical compositions and process for their productionInfo
- Publication number
- YU49699A YU49699A YU49699A YU49699A YU49699A YU 49699 A YU49699 A YU 49699A YU 49699 A YU49699 A YU 49699A YU 49699 A YU49699 A YU 49699A YU 49699 A YU49699 A YU 49699A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- production
- pharmaceutical compositions
- composition
- hydrogel matrix
- bioactive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Abstract
A composition and method are described for the oral administration of bioactive components to vertebrates. The method comprises the step of orally administering the vertebrate a composition comprising a swellable hydrogel matrix and a bioactive composition contained within the hydrogel matrix.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4228097P | 1997-04-02 | 1997-04-02 | |
US6136797P | 1997-10-08 | 1997-10-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU49699A true YU49699A (en) | 2002-12-10 |
Family
ID=26719055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU49699A YU49699A (en) | 1997-04-02 | 1998-04-02 | Pharmaceutical compositions and process for their production |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0975328A1 (en) |
JP (1) | JP2002512607A (en) |
KR (1) | KR20010005952A (en) |
CN (1) | CN1259045A (en) |
AU (1) | AU727053B2 (en) |
BR (1) | BR9808466A (en) |
CA (1) | CA2285457A1 (en) |
IL (1) | IL132176A0 (en) |
NO (1) | NO994757L (en) |
NZ (1) | NZ500075A (en) |
PL (1) | PL335974A1 (en) |
TR (1) | TR199903240T2 (en) |
WO (1) | WO1998043615A1 (en) |
YU (1) | YU49699A (en) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
DE10040592A1 (en) * | 2000-08-15 | 2002-03-07 | Aventis Res & Tech Gmbh & Co | Composition for oral administration of drugs, e.g. peptidomimetics or sparingly soluble antibiotics, containing hydrogel copolymer of unsaturated acid and polyalkylene glycol ester as resorption improver |
US6878384B2 (en) | 2001-03-13 | 2005-04-12 | Microvention, Inc. | Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
WO2003080149A2 (en) | 2002-03-20 | 2003-10-02 | Mannkind Corporation | Inhalation apparatus |
DE602005024413D1 (en) | 2004-08-20 | 2010-12-09 | Mannkind Corp | CATALYSIS OF DIKETOPIPERAZINE SYNTHESIS |
ES2540886T3 (en) | 2004-08-23 | 2015-07-14 | Mannkind Corporation | Dicetopiperazine salts for drug administration |
WO2006110448A2 (en) * | 2005-04-07 | 2006-10-19 | Drexel University | Bioactive thermogelling polymer systems and methods of their use |
CN101287443B (en) | 2005-07-29 | 2013-05-29 | 斯蒂茨廷格罗宁根药物研究中心 | Pulse releasing system controlled by pH, preparation method and application thereof |
WO2007016600A2 (en) * | 2005-08-01 | 2007-02-08 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
KR101557502B1 (en) | 2005-09-14 | 2015-10-06 | 맨카인드 코포레이션 | Method of drug formulation based on increasing the affinity of active agents for crystalline micropaticle surfaces |
AU2007216966C1 (en) | 2006-02-22 | 2014-03-20 | Mannkind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
JP2010500917A (en) | 2006-06-15 | 2010-01-14 | マイクロベンション, インコーポレイテッド | Embolization device composed of expandable polymer |
CA2709379C (en) | 2007-12-21 | 2016-08-16 | Microvention, Inc. | Hydrogel filaments for biomedical uses |
PL2293833T3 (en) | 2008-06-13 | 2016-08-31 | Mannkind Corp | A dry powder inhaler and system for drug delivery |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
EP2609954B1 (en) | 2008-06-20 | 2021-12-29 | MannKind Corporation | An interactive apparatus for real-time profiling of inhalation efforts |
TWI532497B (en) | 2008-08-11 | 2016-05-11 | 曼凱公司 | Use of ultrarapid acting insulin |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
EP2405963B1 (en) | 2009-03-11 | 2013-11-06 | MannKind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
KR20180079458A (en) | 2009-06-12 | 2018-07-10 | 맨카인드 코포레이션 | Diketopiperazine microparticles with defined specific surface areas |
HUP0900482A2 (en) | 2009-08-03 | 2011-03-28 | Cera Med Kft | Pharmaceutical formulation for oral administration |
EP2480166B1 (en) | 2009-09-24 | 2017-11-29 | Microvention, Inc. | Injectable hydrogel filaments for biomedical uses |
WO2011053555A1 (en) | 2009-10-26 | 2011-05-05 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US9016147B2 (en) | 2009-11-03 | 2015-04-28 | Mannkind Corporation | Apparatus and method for simulating inhalation efforts |
CA2801936C (en) | 2010-06-21 | 2021-06-01 | Mannkind Corporation | Dry powder drug delivery system and methods |
EP2694402B1 (en) | 2011-04-01 | 2017-03-22 | MannKind Corporation | Blister package for pharmaceutical cartridges |
US9456823B2 (en) | 2011-04-18 | 2016-10-04 | Terumo Corporation | Embolic devices |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
EP2776053A1 (en) | 2011-10-24 | 2014-09-17 | MannKind Corporation | Methods and compositions for treating pain |
WO2013158781A1 (en) | 2012-04-18 | 2013-10-24 | Microvention, Inc. | Embolic devices |
AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
EP2911690A1 (en) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalable influenza vaccine compositions and methods |
KR102499439B1 (en) | 2013-03-15 | 2023-02-13 | 맨카인드 코포레이션 | Microcrystalline diketopiperazine compositions and methods |
MX2020009878A (en) | 2013-07-18 | 2022-07-27 | Mannkind Corp | Heat-stable dry powder pharmaceutical compositions and methods. |
WO2015021044A1 (en) * | 2013-08-05 | 2015-02-12 | University Of Rochester | Compositions and methods for stimuli-responsive release of a therapeutic agent |
JP2016530930A (en) | 2013-08-05 | 2016-10-06 | マンカインド コーポレイション | Ventilation device and method |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10124090B2 (en) | 2014-04-03 | 2018-11-13 | Terumo Corporation | Embolic devices |
CN110433326A (en) | 2014-04-29 | 2019-11-12 | 微仙美国有限公司 | Polymer comprising activating agent |
US10092663B2 (en) | 2014-04-29 | 2018-10-09 | Terumo Corporation | Polymers |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
US10265405B2 (en) | 2014-11-18 | 2019-04-23 | Board Of Regents, The University Of Texas System | Polymers for delivery of factor VIII and/or factor IX |
WO2016201250A1 (en) | 2015-06-11 | 2016-12-15 | Microvention, Inc. | Expansile device for implantation |
WO2024130101A1 (en) * | 2022-12-16 | 2024-06-20 | Wake Forest University Health Sciences | Hydrogel compositions and methods of making and using the same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2976576A (en) * | 1956-04-24 | 1961-03-28 | Wichterle Otto | Process for producing shaped articles from three-dimensional hydrophilic high polymers |
US3220960A (en) * | 1960-12-21 | 1965-11-30 | Wichterle Otto | Cross-linked hydrophilic polymers and articles made therefrom |
FR1586811A (en) * | 1966-01-06 | 1970-03-06 | ||
US3607848A (en) * | 1967-08-07 | 1971-09-21 | Ceskoslovenska Akademie Ved | Method for preparing insoluble,cross-linked organic hydrogels comprising copolymers of glycol monoesters with diesters |
US3885078A (en) * | 1968-03-06 | 1975-05-20 | Ceskoslovenska Akademie Ved | Hydrogel laminates and method of manufacturing thereof |
US4071508A (en) * | 1975-02-11 | 1978-01-31 | Plastomedical Sciences, Inc. | Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates |
FR2601026B1 (en) * | 1986-04-15 | 1988-09-16 | Rhone Poulenc Chimie | DRY MATERIAL MOISTURIZABLE IN AN AQUEOUS GEL CONTAINING PARTICLES OF DISPERSE POLYMERS, METHOD FOR ITS PREPARATION AND ITS APPLICATION IN BIOLOGY |
-
1998
- 1998-04-02 YU YU49699A patent/YU49699A/en unknown
- 1998-04-02 JP JP54201598A patent/JP2002512607A/en active Pending
- 1998-04-02 NZ NZ500075A patent/NZ500075A/en unknown
- 1998-04-02 CN CN98805351A patent/CN1259045A/en active Pending
- 1998-04-02 KR KR1019997009029A patent/KR20010005952A/en not_active Application Discontinuation
- 1998-04-02 WO PCT/US1998/006563 patent/WO1998043615A1/en not_active Application Discontinuation
- 1998-04-02 CA CA002285457A patent/CA2285457A1/en not_active Abandoned
- 1998-04-02 PL PL98335974A patent/PL335974A1/en unknown
- 1998-04-02 BR BR9808466-6A patent/BR9808466A/en not_active IP Right Cessation
- 1998-04-02 TR TR1999/03240T patent/TR199903240T2/en unknown
- 1998-04-02 IL IL13217698A patent/IL132176A0/en unknown
- 1998-04-02 AU AU68809/98A patent/AU727053B2/en not_active Ceased
- 1998-04-02 EP EP98914454A patent/EP0975328A1/en not_active Withdrawn
-
1999
- 1999-09-30 NO NO994757A patent/NO994757L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0975328A1 (en) | 2000-02-02 |
CN1259045A (en) | 2000-07-05 |
KR20010005952A (en) | 2001-01-15 |
TR199903240T2 (en) | 2000-05-22 |
NZ500075A (en) | 2001-03-30 |
CA2285457A1 (en) | 1998-10-08 |
NO994757L (en) | 1999-11-29 |
NO994757D0 (en) | 1999-09-30 |
IL132176A0 (en) | 2001-03-19 |
WO1998043615A1 (en) | 1998-10-08 |
AU6880998A (en) | 1998-10-22 |
AU727053B2 (en) | 2000-11-30 |
PL335974A1 (en) | 2000-06-05 |
BR9808466A (en) | 2001-08-07 |
JP2002512607A (en) | 2002-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU49699A (en) | Pharmaceutical compositions and process for their production | |
MY137768A (en) | Rapidly disintegrating methylcellulose tablets | |
AU6060896A (en) | Oral 1alpha-hydroxyprevitamin D | |
AU1534699A (en) | Osmotic dosage form comprising first and second coats | |
MY128046A (en) | Rapidly disintegrating methylcellulose tablets | |
PL365940A1 (en) | Novel pharmaceutical composition for administering n-0923 | |
IL109800A (en) | Sustained release drug formulation containing a tramadol salt comprising cellulose ether and/or cellulose ester having a viscosity between 3,000 and 150,000 mPas | |
BG105568A (en) | Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent | |
IL143375A0 (en) | Sustained release matrix systems for highly soluble drugs | |
AU5157590A (en) | Pharmaceutical compositions for oral administration | |
EP1026157A3 (en) | Method for the synthesis of huperzine A and analogs thereof and compounds useful therein | |
PL344564A1 (en) | Matrix tablet enabling prolonged release of trimethiazidine after oral administration and method of making such tablet | |
HU9800781D0 (en) | Propanolamine derivatives, process for producing them, pharmaceutical compositions containing them and their use | |
BR9508034A (en) | Process and apparatus for preparing an edible unit which rapidly dissolves said composition unit to release an active ingredient. Process for administering an active ingredient to a human host and provisional product for manufacturing the edible unit. | |
AU4560297A (en) | Pharmaceutical microspheres of valproic acid for oral administration | |
ATE215817T1 (en) | SOLID DRUGS CONTAINING MILTEFOSINE FOR ORAL ADMINISTRATION IN THE TREATMENT OF LEISHMANIASIS | |
AU2003271811A1 (en) | Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same | |
ATE195074T1 (en) | ANTI-COUGH COMPOSITION CONTAINING AN ANTITUSSIVE AND BENZYDAMINE | |
IT1261471B (en) | PHARMACEUTICAL COMPOSITION FOR RECTAL ADMINISTRATION IN THE TREATMENT OF HEADACHE AND RELATED METHOD OF PREPARATION AND USE. | |
AU7775398A (en) | Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions | |
MX9709838A (en) | Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions. | |
AU7735798A (en) | Pharmaceutical composition for oral administration | |
GEP20032924B (en) | Novel Furan Diarylmethylidene Derivatives, Method for Their Preparation and Pharmaceutical Composition | |
CA2361081A1 (en) | Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis | |
SI0831820T1 (en) | Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |